In a decisive move, Barclays has initiated coverage of Hims & Hers Health with an Overweight rating, setting a price target of $48 per share. This projec ...

Once a celebrated star in the technology sector, The Trade Desk is now grappling with a severe decline in its share price, ...

Shares of Procter & Gamble, the consumer staples behemoth behind household names like Pampers and Gillette, have recently touched a two-year low near $13 ...

Investors in Altria Group are currently presented with a compelling yet precarious proposition. The tobacco giant is deploying substantial shareholder return ...

Investor sentiment toward Synopsys has notably improved just hours before the company is scheduled to release its ...

The future direction of Kraft Heinz is at the center of a strategic tug-of-war, creating a stark divide among major investors ...

After a prolonged period of consolidation, the Cardano ecosystem is showing signs of renewed vigor. A combination of a major ...

Eli Lilly and Company has finalized its acquisition of Adverum Biotechnologies, a move that delivers a promising gene therapy ...

A dual catalyst event on Tuesday underscored Taiwan Semiconductor Manufacturing Company's (TSMC) entrenched dominance in the global semiconductor sector. The ...

Market observers are noting Reinsurance Group of America's (RGA) continued execution of its active portfolio management strategy. The company's recent sale o ...

A significant strategic realignment appears to be underway at Meta Platforms. After years of channeling billions into CEO ...

For investors in solid-state battery technology, patience has been a recurring requirement. This was recently underscored by QuantumScape shares declining ap ...